Avantax Advisory Services’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$314K Buy
+2,498
New +$311K ﹤0.01% 1875
2024
Q3
– Sell
-1,117
Closed -$259K – 2129
2024
Q2
$259K Buy
+1,117
New +$243K ﹤0.01% 1796
2023
Q4
– Sell
-833
Closed -$214K – 1580
2023
Q3
$214K Sell
833
-13
-2% -$3.48K ﹤0.01% 1391
2023
Q2
$241K Sell
846
-43
-5% -$12.8K ﹤0.01% 1303
2023
Q1
$247K Sell
889
-31
-3% -$8.58K ﹤0.01% 1255
2022
Q4
$255K Buy
920
+19
+2% +$5.37K ﹤0.01% 1189
2022
Q3
$241K Buy
+901
New +$191K ﹤0.01% 1112
2022
Q2
– Sell
-1,127
Closed -$236K – 1313
2022
Q1
$236K Sell
1,127
-36
-3% -$7.83K ﹤0.01% 1118
2021
Q4
$279K Sell
1,163
-1,012
-47% -$260K ﹤0.01% 1011
2021
Q3
$617K Buy
2,175
+648
+42% +$212K 0.01% 637
2021
Q2
$528K Buy
+1,527
New +$463K 0.01% 693
2020
Q4
– Sell
-1,753
Closed -$497K – 970
2020
Q3
$497K Buy
+1,753
New +$489K 0.01% 784
2020
Q2
– Sell
-830
Closed -$264K – 854
2020
Q1
$264K Buy
+830
New +$252K 0.01% 625

Other funds holding BIIB

Avantax Advisory Services's BIIB Position: Q2 2025 in Review

Avantax Advisory Services opened a new position in Biogen (BIIB) in Q2 2025: 2,498 shares worth $314K. The stake represents ﹤0.01% of the portfolio and ranks #1875 among its holdings. This is a return to the name: Avantax Advisory Services previously reported a position in BIIB as recently as Q2 2024.

Avantax Advisory Services first reported a position in BIIB in Q1 2020 and has held it in 13 quarters since. The position peaked at $617K in Q3 2021. 866 funds tracked by Wall St. Rank hold BIIB as of Q2 2025.

  • Avantax Advisory Services held 2,498 shares of Biogen worth $314K as of Q2 2025.
  • Biogen was a new Avantax Advisory Services position in Q2 2025.
  • Biogen made up ﹤0.01% of Avantax Advisory Services's portfolio in Q2 2025, its #1875 holding.
  • Avantax Advisory Services first reported a position in Biogen in Q1 2020 and has held it in 13 quarters since.
  • Avantax Advisory Services's Biogen position peaked at $617K in Q3 2021.
  • 866 funds tracked by Wall St. Rank held Biogen as of Q2 2025.

Based on Avantax Advisory Services's 13F filing for Q2 2025, filed 8 Aug 2025.